These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7704243)

  • 1. N-ras mutation of thyroid tumor with special reference to the follicular type.
    Oyama T; Suzuki T; Hara F; Iino Y; Ishida T; Sakamoto A; Nakajima T
    Pathol Int; 1995 Jan; 45(1):45-50. PubMed ID: 7704243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability of Ha-ras (codon 12) proto-oncogene mutations in diverse thyroid cancers.
    Bouras M; Bertholon J; Dutrieux-Berger N; Parvaz P; Paulin C; Revol A
    Eur J Endocrinol; 1998 Aug; 139(2):209-16. PubMed ID: 9724079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Ras mutations in thyroid neoplasia.
    Esapa CT; Johnson SJ; Kendall-Taylor P; Lennard TW; Harris PE
    Clin Endocrinol (Oxf); 1999 Apr; 50(4):529-35. PubMed ID: 10468914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The associations between RAS mutations and clinical characteristics in follicular thyroid tumors: new insights from a single center and a large patient cohort.
    Fukahori M; Yoshida A; Hayashi H; Yoshihara M; Matsukuma S; Sakuma Y; Koizume S; Okamoto N; Kondo T; Masuda M; Miyagi Y
    Thyroid; 2012 Jul; 22(7):683-9. PubMed ID: 22650231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomas.
    Manenti G; Pilotti S; Re FC; Della Porta G; Pierotti MA
    Eur J Cancer; 1994; 30A(7):987-93. PubMed ID: 7946598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of ras mutation in the progression of thyroid carcinoma of follicular epithelial origin.
    Motoi N; Sakamoto A; Yamochi T; Horiuchi H; Motoi T; Machinami R
    Pathol Res Pract; 2000; 196(1):1-7. PubMed ID: 10674266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point mutations of ras oncogenes are an early event in thyroid tumorigenesis.
    Namba H; Rubin SA; Fagin JA
    Mol Endocrinol; 1990 Oct; 4(10):1474-9. PubMed ID: 2283998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Specific amplification by PCR for N-ras mutation in thyroid follicular cartinoma].
    Taniyama M; Kaihara M
    Nihon Rinsho; 1994 Apr; 52(4):1075-80. PubMed ID: 8196166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific pattern of RAS oncogene mutations in follicular thyroid tumors.
    Vasko V; Ferrand M; Di Cristofaro J; Carayon P; Henry JF; de Micco C
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2745-52. PubMed ID: 12788883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalences of Gs alpha, ras, p53 mutations and ret/PTC rearrangement in differentiated thyroid tumours in a Korean population.
    Park KY; Koh JM; Kim YI; Park HJ; Gong G; Hong SJ; Ahn IM
    Clin Endocrinol (Oxf); 1998 Sep; 49(3):317-23. PubMed ID: 9861322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ha-ras oncogene (codon 12) mutation in thyroid carcinogenesis: analysis of 60 benign and malignant thyroid tumors.
    Bouras M; Parvaz P; Berger N; Paulin C; Revol A
    Ann Biol Clin (Paris); 1995; 53(10-11):549-55. PubMed ID: 8787281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High rates of ras codon 61 mutation in thyroid tumors in an iodide-deficient area.
    Shi YF; Zou MJ; Schmidt H; Juhasz F; Stensky V; Robb D; Farid NR
    Cancer Res; 1991 May; 51(10):2690-3. PubMed ID: 2021946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of K-ras codon 12 mutations and p53 overexpression in colorectal nodule-aggregating tumors.
    Kusaka T; Fukui H; Sano Y; Ueda Y; Chiba T; Fujimori T
    J Gastroenterol Hepatol; 2000 Oct; 15(10):1151-7. PubMed ID: 11106095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of activating ras mutations in morphologically characterized thyroid nodules.
    Ezzat S; Zheng L; Kolenda J; Safarian A; Freeman JL; Asa SL
    Thyroid; 1996 Oct; 6(5):409-16. PubMed ID: 8936664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-ras 61 oncogene mutations in Hürthle cell tumors.
    Schark C; Fulton N; Jacoby RF; Westbrook CA; Straus FH; Kaplan EL
    Surgery; 1990 Dec; 108(6):994-9; discussion 999-1000. PubMed ID: 2247846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific PCR amplification for N-ras mutations in neoplastic thyroid diseases.
    Kaihara M; Taniyama M; Tadatomo J; Tobe T; Tomita M; Ito K; Ban Y; Katagiri T
    Endocr J; 1994 Jun; 41(3):301-8. PubMed ID: 7951583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ras oncogene mutations in thyroid tumors: polymerase chain reaction-restriction-fragment-length polymorphism analysis from paraffin-embedded tissues.
    Capella G; Matias-Guiu X; Ampudia X; de Leiva A; Perucho M; Prat J
    Diagn Mol Pathol; 1996 Mar; 5(1):45-52. PubMed ID: 8919545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective occurrence of ras mutations in benign and malignant thyroid follicular neoplasms in Taiwan.
    Liu RT; Hou CY; You HL; Huang CC; Hock-Liew ; Chou FF; Wang PW; Cheng JT
    Thyroid; 2004 Aug; 14(8):616-21. PubMed ID: 15320975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point mutations of ras and Gs alpha subunit genes in thyroid tumors.
    Horie H; Yokogoshi Y; Tsuyuguchi M; Saito S
    Jpn J Cancer Res; 1995 Aug; 86(8):737-42. PubMed ID: 7559096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of tumors meeting diagnostic criteria for the non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
    Pool C; Walter V; Bann D; Goldenberg D; Broach J; Hennessy M; Cottrill E; Washburn E; Williams N; Crist H; Imamura Y; Warrick JI
    Virchows Arch; 2019 Mar; 474(3):341-351. PubMed ID: 30645670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.